Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · AXSM · as of Jun 8, 2026
Activity summary
Buy transactions
3
P-Purchase only
Sell transactions
37
12 Months
Buy/Sell ratio
0.08
Buy/Sell (by trades)
Overall sentiment
Axsome Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
AXSM insider buying and selling by quarter
AXSM insider selling · AXSM insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · AXSM ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
AXSM executive sell shares · AXSM board member insider trading · AXSM insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 29, 2026 | Coleman Mark Director | Sale | 6,000 | $1.40M⚡ | Form 4 |
| Jun 1, 2026 | Coleman Mark Director | Sale | 6,000 | $1.38M⚡ | Form 4 |
| Jun 2, 2026 | Coleman Mark Director | Sale | 5,537 | $1.24M⚡ | Form 4 |
| May 4, 2026 | Jacobson Mark L. COO | Option | 4,517 | $58K | Form 4 |
| May 5, 2026 | Jacobson Mark L. COO | Option | 233 | $3K | Form 4 |
| May 5, 2026 | Jacobson Mark L. COO | Sale | 233 | $53K | Form 4 |
| May 4, 2026 | Jacobson Mark L. COO | Sale | 4,517 | $1.03M⚡ | Form 4 |
| Apr 22, 2026 | Maizel Ari Chief Commercial Officer | Option | 7,500 | $530K | Form 4 |
| Apr 22, 2026 | Maizel Ari Chief Commercial Officer | Sale | 7,500 | $1.37M⚡ | Form 4 |
| Feb 26, 2026 | Coleman Mark Director | Sale | 25,000 | $4.03M⚡ | Form 4 |
| Feb 26, 2026 | Jacobson Mark L. COO | Option | 35,378 | $101K | Form 4 |
| Feb 26, 2026 | Jacobson Mark L. COO | Sale | 35,378 | $5.73M⚡ | Form 4 |
| Feb 23, 2026 | Coleman Mark Director | Option | 6,250 | $31K | Form 4 |
| Feb 20, 2026 | Coleman Mark Director | Option | 12,485 | $62K | Form 4 |
| Feb 10, 2026 | Coleman Mark Director | Option | 5,193 | $42K | Form 4 |
| Feb 2, 2026 | TABUTEAU HERRIOT CEO · Director | Option | 32,410 | $260K | Form 4 |
| Feb 2, 2026 | TABUTEAU HERRIOT CEO · Director | Sale | 32,410 | $6.02M⚡ | Form 4 |
| Jan 22, 2026 | Pizzie Nick CFO | Option | 12,000 | $42K | Form 4 |
| Jan 22, 2026 | Pizzie Nick CFO | Sale | 12,000 | $2.26M⚡ | Form 4 |
| Jan 21, 2026 | Maizel Ari Chief Commercial Officer | Option | 7,500 | $530K | Form 4 |
| Jan 21, 2026 | Maizel Ari Chief Commercial Officer | Sale | 7,500 | $1.38M⚡ | Form 4 |
| Jan 5, 2026 | TABUTEAU HERRIOT CEO · Director | Option | 78,703 | $631K | Form 4 |
| Jan 7, 2026 | TABUTEAU HERRIOT CEO · Director | Option | 31,261 | $251K | Form 4 |
| Jan 6, 2026 | TABUTEAU HERRIOT CEO · Director | Option | 29,450 | $236K | Form 4 |
| Jan 5, 2026 | TABUTEAU HERRIOT CEO · Director | Sale | 78,703 | $13.48M⚡ | Form 4 |
Maizel Ari
Chief Commercial Officer
Date
Apr 22
Shares
7,500
Price
$70.73
Value
$530K
Maizel Ari
Chief Commercial Officer
Date
Apr 22
Shares
7,500
Price
$182.42
Value
$1.37M ⚡
TABUTEAU HERRIOT
CEO · Director
Date
Feb 2
Shares
32,410
Price
$185.60
Value
$6.02M ⚡
Maizel Ari
Chief Commercial Officer
Date
Jan 21
Shares
7,500
Price
$70.73
Value
$530K
Maizel Ari
Chief Commercial Officer
Date
Jan 21
Shares
7,500
Price
$184.44
Value
$1.38M ⚡
TABUTEAU HERRIOT
CEO · Director
Date
Jan 5
Shares
78,703
Price
$171.28
Value
$13.48M ⚡
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About AXSM insider trading
AXSM insider trades
Axsome Therapeutics, Inc. (AXSM) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including TABUTEAU HERRIOT (CEO · Director), Jacobson Mark L. (COO), Coleman Mark (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. AXSM insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Axsome Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
AXSM insider trading · 5 questionsThe insiders of Axsome Therapeutics, Inc. (AXSM) include executives and directors such as TABUTEAU HERRIOT (CEO · Director), Jacobson Mark L. (COO), Coleman Mark (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026